Adagene Alternatives & Competitors
12 companies similar to Adagene — Redefining the design and discovery of therapeutic antibodies
Companies similar to Adagene
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Rival Readout
Competing with Adagene? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NBE-Therapeutics AG
Next generation antibody drug conjugates
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Merus N.V.
Merus was acquired by Genmab. To see what’s new, visit Genmab.
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
AVEO Oncology
Committed to delivering medicines that provide a better life for patients with cancer.
LabGenius Therapeutics
Combining human and machine intelligence to discover the next generation of therapeutic an...
About Adagene
Adagene Inc. (Nasdaq: ADAG) is a pioneering biotechnology company established in 2012, with a commitment to transforming the design and discovery of antibody-based cancer immunotherapies. The company’s slogan, "Redefining the design and discovery of therapeutic antibodies," underscores its innovative approach in this s...
Antibody Discovery, Antibody Engineering, Drug Development
Pharmaceutical Companies, Healthcare Institutions, Biotech Investors
Antibody Discovery, Cancer Immunotherapy, Computational Biology, DPL Platform, NEObody Technology, SAFEbody Technology, POWERbody Technology, Immuno-oncology, Novel Epitopes, Smart Antibody Technology, Clinical-stage Biotech, Therapeutic Antibody Development, Strategic Collaborations
B2B, Platform, B2B2B
Licensing, Service Fee, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Adagene: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Adagene on 15 Jun 2026. The 12 companies listed here were last checked between 11 Nov 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.